Comparative Analysis of Potential Side Effects of Targeted Oral Hypoglycemic Agents Using Spontaneous Adverse Event Reports and Social Media Data. [PDF]
Pharmacoepidemiol Drug SafOh SH, Park DY, Song YK.
europepmc +1 more source
DPP4 inhibitors as a novel therapeutic strategy in colorectal cancer: Integrating network biology and experimental insights. [PDF]
PLoS OneBardaweel SK +3 more
europepmc +1 more source
Sita- and saxagliptin use and autoantibodies to autoimmune bullous diseases: A cross-sectional study. [PDF]
J Eur Acad Dermatol VenereolDräger S +8 more
europepmc +1 more source
Reversing 20 years of diabetes using the carnivore diet in India: a case report. [PDF]
Clin Nutr ResVerma A.
europepmc +1 more source
Case Report: NEUROD1 c.-108G>C mutation in a ketosis-prone MODY6 patient: implications for genetic testing and DPP-4 inhibitor therapy. [PDF]
Front Endocrinol (Lausanne)Shao Z, Xu L.
europepmc +1 more source
DPP-4 inhibitors for preventing post-stroke cognitive impairment in diabetic patients with acute ischemic stroke: a retrospective cohort study. [PDF]
Am J Transl ResFu H, Liu J, Wu J, Zou F.
europepmc +1 more source
Comparative thromboembolic risk and polypharmacy-related drug-drug interaction signals among antidiabetic medications: a large-scale FAERS pharmacovigilance study. [PDF]
Front PharmacolBafail D, Ghazal H.
europepmc +1 more source
DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing. [PDF]
Curr Issues Mol BiolMuddather HF, Schelz Z, Zupkó I.
europepmc +1 more source
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence. [PDF]
J Diabetes ResAlfonso Arvez MJ +4 more
europepmc +1 more source